Trial intelligence / Profile preview

5-fluorouracil vs Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts

NCT06096220Phase 4Enrolling by invitation

Sponsor
University of Belgrade
Start
Jun 2023
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fluorouracil 5% cream in Odontogenic keratocyst (OKC) (2 arms), sponsored by University of Belgrade. Primary endpoint: Recurrence rate at 5 years. Started Jun 2023; status: enrolling by invitation.

02

Drugs

fluorouracil 5% cream
03

Conditions

Odontogenic keratocyst (OKC)

Beyond the preview

Go deeper on NCT06096220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06096220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call